-
Etrasimod (CAS: 1206123-37-6)
API’s Name Indication Innovator Patent Expiry Date(The U.S) Etrasimod Ulceratuve Colitis(UC) Arena(Pfizer) Mar.05,2030 -
Etelcacetide (CAS: 1262780-97-1)
API’s Name Indication Innovator Patent Expiry Date(The U.S) Etelcacetide Secondary hyperparathyroidism(HPT) Amgen Feb. 7,2031 -
Eltrombopag
API’s Name Indication Innovator Patent Expiry Date(The U.S) Eltrombopag ITP & Aplastic anemia Novartis & GSK May. 20, 2023 -
Enalapril Maleate
API’s Name Indication Specification US DMF EU DMF CEP Enalapril Maleate Hypertension USP/EP